Schneeberger Daniel

CIK 0001861120

10% Owner

Filings

Latest May 21, 2026

Issuers covered

Showing

9 of 9

Page 1

Track record

11 of 25 open-market trades scored (44% price coverage) - 14 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	11	73%	+13.1%	+13.8%	+32.1%	-19.1%
90 days	8	63%	+8.7%	+34.7%	+34.7%	-34.6%
180 days	8	100%	+40.7%	+51.2%	+51.2%	+23.1%
365 days	5	100%	+20.9%	+20.9%	+20.9%	+20.9%

Issuers

Companies where Schneeberger Daniel has filed

Ticker	Issuer	Filings	Last filed
KROS	Keros Therapeutics, Inc.	4	Oct 15, 2025
RLYB	Rallybio Corp	4	May 20, 2026
INM	Inmed Pharmaceuticals Inc.	1	May 21, 2026

All filings

9 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
May 21, 2026	INMInmed Pharmaceuticals Inc.	PPurchase	200,000	$1.5604	$312,080
May 20, 2026	RLYBRallybio Corp	PPurchase	10,000	$13.9822	$139,822
May 15, 2026	RLYBRallybio Corp	PPurchase	75,178	$14.00	$1,052,492
May 13, 2026	RLYBRallybio Corp	PPurchase	25,000	$14.00	$350,000
May 6, 2026	RLYBRallybio Corp	PPurchase	116,904	$13.9705	$1,633,207
Oct 15, 2025	KROSKeros Therapeutics, Inc.	SSale	4,391,237	$17.75	$77,944,457
Jun 24, 2025	KROSKeros Therapeutics, Inc.	XITM Exercise	1,400	$70.00	$98,000
Jun 12, 2025	KROSKeros Therapeutics, Inc.	Holdings only	-	-	-
Apr 11, 2025	KROSKeros Therapeutics, Inc.	PPurchase	500,000	$10.33	$5,165,000

Showing 1-9 of 9

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value